Repeated assessment of neuropsychological deficits in multiple sclerosis using the Symbol Digit Modalities Test and the MS Neuropsychological Screening Questionnaire

Background Brief cognitive performance tests and self-report measures of neuropsychological symptoms have been proposed for screening purposes in multiple sclerosis (MS) clinics. To better understand the reliability of screening methods, two tests, the Symbol Digit Modalities Test (SDMT) and the MS Neuropsychological Screening Questionnaire (MSNQ), were administered to 76 patients with MS and 25 healthy controls, matched on demographic characteristics. Methods Tests were administered at monthly intervals, over 6 months. In addition, the Beck Depression Inventory Fast Screen for medical patients (BDIFS) was administered to monitor for changes in depression. Our objectives were to determine the reliability of these measures and the relative contribution of cognitive impairment and depression in predicting self-report MSNQ scores. Results Results showed that both the SDMT and MSNQ have good to excellent reproducibility over repeated testing. In MS, there are minimal practice effects over successive tests, in the order of 0.2 SD for SDMT and minimal change in the MSNQ. Regression analyses modeled to predict MSNQ based on SDMT and BDIFS showed significant contribution for both, but with the majority of variance being accounted for depression. Conclusions We conclude that these brief screening tests provide some independent information about the mental status of patients with MS and are reliable, even when used in monthly, successive examinations.

[1]  Ron Dumont,et al.  Delis‐Kaplan Executive Function System , 2008 .

[2]  R. Benedict,et al.  Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients , 2008, Journal of Neurology.

[3]  J. DeLuca,et al.  Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes. , 2007, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[4]  C R G Guttmann,et al.  Thalamic atrophy and cognition in multiple sclerosis , 2007, Neurology.

[5]  F. Munschauer,et al.  Screening for cognitive impairment in multiple sclerosis using the Symbol Digit Modalities Test , 2007, Multiple sclerosis.

[6]  Robert Zivadinov,et al.  Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis. , 2006, Archives of neurology.

[7]  R. Benedict,et al.  Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS) , 2006, Journal of the International Neuropsychological Society.

[8]  R. Benedict,et al.  Predicting neuropsychological abnormalities in multiple sclerosis , 2006, Journal of the Neurological Sciences.

[9]  R. Benedict Effects of using same- versus alternate-form memory tests during short-interval repeated assessments in multiple sclerosis , 2005, Journal of the International Neuropsychological Society.

[10]  R. Benedict,et al.  Interpreting patient/informant discrepancies of reported cognitive symptoms in MS , 2005, Journal of the International Neuropsychological Society.

[11]  R. Benedict Integrating Cognitive Function Screening and Assessment into the Routine Care of Multiple Sclerosis Patients , 2005, CNS Spectrums.

[12]  R. Bakshi,et al.  Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change , 2005, Journal of the Neurological Sciences.

[13]  R. Benedict,et al.  Reliable screening for neuropsychological impairment in multiple sclerosis , 2004, Multiple sclerosis.

[14]  L. Krupp,et al.  Donepezil improved memory in multiple sclerosis in a randomized clinical trial , 2004, Neurology.

[15]  N. De Stefano,et al.  Neocortical volume decrease in relapsing–remitting MS patients with mild cognitive impairment , 2004, Neurology.

[16]  Jared M. Bruce,et al.  Self-Reported Everyday Memory and Depression in Patients With Multiple Sclerosis , 2004, Journal of clinical and experimental neuropsychology.

[17]  Rohit Bakshi,et al.  Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. , 2004, Archives of neurology.

[18]  Grant L Iverson,et al.  Interpreting Change on ImPACT Following Sport Concussion , 2003, The Clinical neuropsychologist.

[19]  R. Benedict,et al.  Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis , 2003, Multiple sclerosis.

[20]  Zhengrong Liang,et al.  Cognitive performance and MR markers of cerebral injury in cognitively impaired MS patients , 2003, Neurology.

[21]  R. Benedict,et al.  Screening for multiple sclerosis cognitive impairment using a self-administered 15-item questionnaire , 2003, Multiple sclerosis.

[22]  Ralph H B Benedict,et al.  Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach , 2002, The Clinical neuropsychologist.

[23]  Rohit Bakshi,et al.  Bicaudate ratio as a magnetic resonance imaging marker of brain atrophy in multiple sclerosis. , 2002, Archives of neurology.

[24]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[25]  R L Priore,et al.  Personality disorder in multiple sclerosis correlates with cognitive impairment. , 2001, The Journal of neuropsychiatry and clinical neurosciences.

[26]  R. Benedict,et al.  Neuropsychological counseling improves social behavior in cognitively-impaired multiple sclerosis patients , 2000, Multiple sclerosis.

[27]  S. Rourke,et al.  Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. , 1999, Journal of clinical and experimental neuropsychology.

[28]  K. Meador,et al.  The relationship between memory performance, perceived cognitive function, and mood in patients with epilepsy , 1999, Epilepsy Research.

[29]  A J Thompson,et al.  Multiple sclerosis: a preliminary study of selected variables affecting rehabilitation outcome , 1999, Multiple sclerosis.

[30]  S. Reingold,et al.  Defining the clinical course of multiple sclerosis , 1996, Neurology.

[31]  R. Paul,et al.  Demographic, Clinical, and Cognitive Characteristics of Multiple Sclerosis Patients Who Continue to Work , 1995 .

[32]  S. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[33]  Stephen M. Rao,et al.  Cognitive dysfunction in multiple sclerosis. , 1991, Neurology.

[34]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[35]  A. Benton Contributions to Neuropsychological Assessment: A Clinical Manual , 1983 .

[36]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[37]  W. Riege Self-Report and Tests of Memory Aging , 1983 .

[38]  P. Fuld,et al.  The Neuropsychological Evaluation of Dementia , 1982 .

[39]  D. Gronwall Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion , 1977, Perceptual and motor skills.

[40]  G. Niederehe,et al.  Memory complaint and impairment in the aged. The effect of depression and altered brain function. , 1975, Archives of general psychiatry.

[41]  A. Verma Donepezil Improved Memory in Multiple Sclerosis in a Randomized Clinical Trial , 2006 .

[42]  A. Anastasi Psychological testing, 6th ed. , 1988 .